| Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2 T Hoffman, K Nissen, J Krambrich, B Rönnberg, D Akaberi, ... Infection ecology & epidemiology 10 (1), 1754538, 2020 | 252 | 2020 |
| Long-distance airborne dispersal of SARS-CoV-2 in COVID-19 wards K Nissen, J Krambrich, D Akaberi, T Hoffman, J Ling, Å Lundkvist, ... Scientific reports 10 (1), 19589, 2020 | 221* | 2020 |
| Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro D Akaberi, J Krambrich, J Ling, C Luni, G Hedenstierna, JD Järhult, ... Redox biology 37, 101734, 2020 | 190 | 2020 |
| Ultralarge virtual screening identifies SARS-CoV-2 main protease inhibitors with broad-spectrum activity against coronaviruses A Luttens, H Gullberg, E Abdurakhmanov, DD Vo, D Akaberi, VO Talibov, ... Journal of the American Chemical Society 144 (7), 2905-2920, 2022 | 179 | 2022 |
| Worldwide prevalence of baseline resistance-associated polymorphisms and resistance mutations in HCV against current direct-acting antivirals N Palanisamy, P Kalaghatgi, D Akaberi, Å Lundkvist, Z Chen, P Hu, ... Antiviral Therapy 23 (6), 485-493, 2018 | 21 | 2018 |
| Targeting the NS2B-NS3 protease of tick-borne encephalitis virus with pan-flaviviral protease inhibitors D Akaberi, A Båhlström, PK Chinthakindi, T Nyman, A Sandström, ... Antiviral Research 190, 105074, 2021 | 19 | 2021 |
| Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment: real-life experience from a multicenter study in Sweden … M Kjellin, H Kileng, D Akaberi, N Palanisamy, AS Duberg, A Danielsson, ... Scandinavian journal of gastroenterology 54 (8), 1042-1050, 2019 | 15 | 2019 |
| Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 protease D Akaberi, PK Chinthakindi, A Båhlström, N Palanisamy, A Sandström, ... Journal of Biomolecular Structure and Dynamics 38 (18), 5526-5536, 2020 | 13 | 2020 |
| Protein backbone flexibility pattern is evolutionarily conserved in the Flaviviridae family: A case of NS3 protease in Flavivirus and Hepacivirus N Palanisamy, D Akaberi, J Lennerstrand Molecular phylogenetics and evolution 118, 58-63, 2018 | 13 | 2018 |
| SARS-CoV-2 in hospital indoor environments is predominantly non-infectious J Krambrich, D Akaberi, J Ling, T Hoffman, L Svensson, M Hagbom, ... Virology journal 18 (1), 109, 2021 | 12 | 2021 |
| Presymptomatic viral shedding and infective ability of SARS-CoV-2; a case report K Nissen, M Hagbom, J Krambrich, D Akaberi, S Sharma, J Ling, ... Heliyon 7 (2), 2021 | 10* | 2021 |
| Baseline dasabuvir resistance in Hepatitis C virus from the genotypes 1, 2 and 3 and modeling of the NS5B-dasabuvir complex by the in silico approach D Akaberi, A Bergfors, M Kjellin, N Kameli, L Lidemalm, B Kolli, ... Infection Ecology & Epidemiology 8 (1), 1528117, 2018 | 10 | 2018 |
| Personalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014–2016: a study of treatment outcome in patients with or without resistance-based DAA-therapy H Kileng, M Kjellin, D Akaberi, A Bergfors, AS Duberg, L Wesslén, ... Scandinavian journal of gastroenterology 53 (10-11), 1347-1353, 2018 | 9 | 2018 |
| Comparative genome analysis of Alkhumra hemorrhagic fever virus with Kyasanur forest disease and tick-borne encephalitis viruses by the in silico approach N Palanisamy, D Akaberi, J Lennerstrand, Å Lundkvist Pathogens and Global Health 112 (4), 210-226, 2018 | 6 | 2018 |
| Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries D Akaberi, M Pourghasemi Lati, J Krambrich, J Berger, G Neilsen, ... Antimicrobial Agents and Chemotherapy 68 (10), e00909-24, 2024 | 1 | 2024 |
| Vector competence of Swedish Culex pipiens mosquitoes for Japanese encephalitis virus J Krambrich, D Akaberi, JF Lindahl, Å Lundkvist, JC Hesson Parasites & Vectors 17 (1), 220, 2024 | 1 | 2024 |
| Study on the temporal and spatial distribution of Culex mosquitoes in Hanoi, Vietnam J Krambrich, T Nguyen-Tien, L Pham-Thanh, S Dang-Xuan, E Andersson, ... Scientific reports 14 (1), 16573, 2024 | | 2024 |
| Reduced Binding between Omicron B. 1.1. 529 and the Human ACE2 Receptor in a Surrogate Virus Neutralization Test for SARS-CoV-2 T Hoffman, L Kolstad, D Akaberi, JD Järhult, B Rönnberg, Å Lundkvist Viruses 15 (6), 1280, 2023 | | 2023 |
| Identification of protease inhibitors against Flaviviruses and Coronaviruses D Akaberi Acta Universitatis Upsaliensis, 2023 | | 2023 |
| Corrigendum to “Presymptomatic viral shedding and infective ability of SARS-CoV-2; a case report”[Heliyon 7,(2),(February 2021), Article e06328] K Nissen, M Hagbom, J Krambrich, D Akaberi, S Sharma, J Ling, ... Heliyon 8 (2), 2022 | | 2022 |
